ANAB
Anaptysbio, Inc.
Clinical-stage biotechnology company focused on immunology therapeutics
CUSIP: 032724106HealthcareUS1 holder
Total Value
$38.63M
Total Shares
543.8K
Net Share Change
+83.9K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$38.63M543.8K shares
ADD+83.9K(+18.2%)